Intravascular large B-cell lymphoma with cutaneous manifestations: A clinicopathologic, immunophenotypic and molecular study of three cases

Journal of Cutaneous Pathology

Volumn 36, Issue 8, 2009, Pages 865-870

  Kong, Yun Yi ^a,b   Dai, Bo ^b,c   Sheng, Wei Qi ^a,b   Yang, Wen Tao ^a,b   Wang, Chao Fu ^a,b   Kong, Jin Cheng ^d   Shi, Da Ren ^a,b,c  

^a Baoding Third Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PREDNISONE; PROTEIN BCL 2; VINCRISTINE SULFATE;

AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELLULITIS; CHILL; CLINICAL FEATURE; ERYTHEMA; FEMALE; FEVER; FOLLOW UP; GENE REARRANGEMENT; HEADACHE; HEMODYNAMIC PARAMETERS; HOSPITAL ADMISSION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; LUMBAR PUNCTURE; MALE; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PATHOGENESIS; PROTEIN EXPRESSION; REMISSION; SKIN BIOPSY; SURVIVAL TIME; TELANGIECTASIA; VASCULITIS; VOMITING;

AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT, B-LYMPHOCYTE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS;

EID: 67650681871     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01168.x     Document Type: Article

References (22)

1. Pfleger VL, Tappeiner J. Zur Kenntnis der systemisierten endotheliomatose der cutanen blutgefaesse (Reticuloendotheliose?). Hautarzt 1959 10 : 363.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of tumours: pathology and genetics of tumours of the hematopoietic and lymphoid tissues. Lyon : IARC Press, 2001 177.
3. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768.
4. Ferreri AJ, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004 127 : 173.
5. Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 2000 111 : 826.
6. Murase T, Nakamura S, Tashiro K, et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. Br J Haematol 1997 99 : 656.
7. Ferreri AJ, Dognini GP, Campo E, et al. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 2007 92 : 486.
8. Bouzani M, Karmiris T, Rontogianni D, et al. Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases with anthracycline-based immunochemotherapy. Oncologist 2006 11 : 923.
9. Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis. A systemic disease with neurologic manifestations. Cancer 1993 71 : 3156.
10. Rubin MA, Cossman J, Freter CE, Azumi N. Intravascular large cell lymphoma coexisting within hemangiomas of the skin. Am J Surg Pathol 1997 21 : 860.
11. Seki K, Miyakoshi S, Lee GH, et al. Prostatic acid phosphatase is a possible tumor marker for intravascular large B-cell lymphoma. Am J Surg Pathol 2004 28 : 1384.
12. Shimizu I, Ichikawa N, Yotsumoto M, Sumi M, Ueno M, Kobayashi H. Asian variant of intravascular lymphomas: aspects of diagnosis and the role of rituximab. Intern Med 2007 46 : 1381.
13. Imai H, Kajimoto K, Taniwaki M, et al. Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: a report of five cases. Pathol Int 2004 54 : 231.
14. Murase T, Yamaguchi M, Suzuki R, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 2007 109 : 478.
15. Kanda M, Suzumiya J, Ohshima K, et al. Analysis of the immunoglobulin heavy chain gene variable region of intravascular large B-cell lymphoma. Virchows Arch 2001 439 : 540.
16. Iqbal J, Neppalli VT, Wright G, et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol 2006 24 : 961.
17. Lozsadi DA, Wieshmann U, Enevoldson TP. Neurological presentation of intravascular lymphoma: report of two cases and discussion of diagnostic challenges. Eur J Neurol 2005 12 : 710.
18. Nakahara T, Saito T, Muroi A, et al. Intravascular lymphomatosis presenting as an ascending cauda equina: conus medullaris syndrome: remission after biweekly CHOP therapy. J Neurol Neurosurg Psychiatry 1999 67 : 403.
19. Vieren M, Sciot R, Robberecht W. Intravascular lymphomatosis of the brain: a diagnostic problem. Clin Neurol Neurosurg 1999 101 : 33.
20. Ossege LM, Postler E, Pleger B, Muller KM, Malin JP. Neoplastic cells in the cerebrospinal fluid in intravascular lymphomatosis. J Neurol 2000 247 : 656.
21. Chang A, Zic JA, Boyd AS. Intravascular large cell lymphoma: a patient with asymptomatic purpuric patches and a chronic clinical course. J Am Acad Dermatol 1998 39 : 318.
22. Roglin J, Boer A. Skin manifestations of intravascular lymphoma mimic inflammatory disease of the skin. Br J Dermatol 2007 157 : 16.